Julien Wicinski

Marseille, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.

Inhibition of the STAT3/Fanconi anemia axis is synthetic lethal with PARP inhibition in breast cancer.

Journal: Nature communications
Published: August 15, 2024

The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer.

The LRP4/YAP axis drives the radiation-tolerant persister (RTP) cell state in breast cancer.

Journal: Theranostics
Published: July 24, 2024

A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumors.

A novel bioinformatic approach reveals cooperation between Cancer/Testis genes in basal-like breast tumors.

Journal: Oncogene
Published: July 26, 2023

Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors.

Production of CRISPRi-engineered primary human mammary epithelial cells with baboon envelope pseudotyped lentiviral vectors.

Journal: STAR protocols
Published: October 21, 2022

MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.

MiR-662 is associated with metastatic relapse in early-stage breast cancer and promotes metastasis by stimulating cancer cell stemness.

Journal: British journal of cancer
Published: September 28, 2022

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells.

BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells.

Journal: Cell death & disease
Published: September 01, 2021

XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation.

XIST loss impairs mammary stem cell differentiation and increases tumorigenicity through Mediator hyperactivation.

Journal: Cell
Published: March 12, 2021

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells.

A genome-wide RNAi screen reveals essential therapeutic targets of breast cancer stem cells.

Journal: EMBO molecular medicine
Published: October 13, 2018

The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling.

The SCRIB Paralog LANO/LRRC1 Regulates Breast Cancer Stem Cell Fate through WNT/β-Catenin Signaling.

Journal: Stem cell reports
Published: December 14, 2017

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

A stemness-related ZEB1-MSRB3 axis governs cellular pliancy and breast cancer genome stability.

Journal: Nature medicine
Published: July 20, 2016

miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling.

miR-600 Acts as a Bimodal Switch that Regulates Breast Cancer Stem Cell Fate through WNT Signaling.

Journal: Cell reports
Published: June 22, 2016

Salinomycin kills cancer stem cells by sequestering iron in lysosomes.

Salinomycin kills cancer stem cells by sequestering iron in lysosomes.

Journal: Nature chemistry
Published: April 21, 2016
Showing 1-12 of 16

Last Updated: 09/26/2026